How to improve the effectiveness of transurethral resection in nonmuscle invasive bladder cancer?

Current Opinion in Urology

Volumn 19, Issue 5, 2009, Pages 504-510

  Cauberg, Evelyne C C ^a   De La Rosette, Jean J M C H ^a   De Reijke, Theo M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Bladder cancer; Recurrence; Review; Transurethral resection

Indexed keywords

BLADDER CANCER; BLADDER TUMOR; CANCER DIAGNOSIS; CANCER INHIBITION; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; DIAGNOSTIC ACCURACY; HUMAN; LOW LEVEL LASER THERAPY; NARROW BAND IMAGING; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMICS; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE; TRANSURETHRAL RESECTION;

CYSTOSCOPY; FLUORESCENT DYES; HUMANS; LASER THERAPY; REOPERATION; TOMOGRAPHY, OPTICAL COHERENCE; URINARY BLADDER NEOPLASMS; UROLOGIC SURGICAL PROCEDURES;

EID: 68949167775     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOU.0b013e32832eb2a3     Document Type: Review

References (37)

1. Brausi M, Collette L, Kurth K, et al. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol 2002; 41:523-531.
2. Pycha A, Palermo S. How to teach the teacher to teach the TUR-B. Int J Surg 2007; 5:81-85.
3. Babjuk M, Oosterlinck W, Sylvester R, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol 2008; 54:303-314.
4. Maruniak NA, Takezawa K, Murphy WM. Accurate pathological staging of urothelial neoplasms requires better cystoscopic sampling. J Urol 2002; 167:2404-2407.
5. Hall MC, Chang SS, Dalbagni G, et al. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update. J Urol 2007; 178:2314-2330.
6. Herr HW, Donat SM. Quality control in transurethral resection of bladder tumours. BJU Int 2008; 102:1242-1246.
7. Dwivedi US, Kumar A, Das SK et al. Relook TURBT in superficial bladder cancer: its importance and its correlation with the tumor ploidy. Urol Oncol 2008. PMID: 18639472. [Epub ahead of print]
8. Schwaibold HE, Sivalingam S, May F, et al. The value of a second transurethral resection forT1 bladder cancer. BJU Int 2006; 97:1199-1201.
9. Han KS, Joung JY, Cho KS, et al. Results of repeated transurethral resection for a second opinion in patients referred for nonmuscle invasive bladder cancer: the referral cancer center experience and review of the literature. J Endourol 2008; 22:2699-2704.
10. Divrik T, Yildirim U, Eroglu AS, et al. Is a second transurethral resection necessary for newly diagnosed pT1 bladder cancer? J Urol 2006; 175: 1258-1261.
11. Miladi M, Peyromaure M, Zerbib M, et al. The value of a second transurethral resection in evaluating patients with bladder tumours. Eur Urol 2003; 43:241-245.
12. Divrik RT, Yildirim U, Zorlu F, et al. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial. J Urol 2006; 175:1641-1644.
13. Mamoulakis C, Trompetter M, de la Rosette J. Bipolar transurethral resection of the prostate: the 'golden standard' reclaims its leading position. Curr Opin Urol 2009; 19:26-32.
14. Rose A, Suttor S, Goebell PJ, et al. Transurethral resection of bladder tumors and prostate enlargement in physiological saline solution (TURIS). A prospective study. Urologe A 2007; 46:1148-1150.
15. Pu XY, Wang HP, Wu YL, et al. Use of bipolar energy for transurethral resection of superficial bladder tumors: long-term results. J Endourol 2008; 22:545-549.
16. Wang DS, Bird VG, Leonard VY, et al. Use of bipolar energy for transurethral resection of bladder tumors: pathologic considerations. J Endourol 2004; 18:578-582.
17. Pietrow PK, Smith JA Jr. Laser treatment for invasive and noninvasive carcinoma of the bladder. J Endourol 2001; 15:415-418.
18. Jonler M, Lund L, Bisballe S. Holmium:YAG laser vaporization of recurrent papillary tumours of the bladder under local anaesthesia. BJU Int 2004; 94:322-325.
19. Soler-Martinez J, Vozmediano-Chicharro R, Morales-Jimenez P, et al. Holmium laser treatment for low grade, low stage, noninvasive bladder cancer with local anesthesia and early instillation of mitomycin C. J Urol 2007; 1 78:2337-2339.
20. Zhu Y, Jiang X, Zhang J, et al. Safety and efficacy of holmium laser resection for primary nonmuscle-invasive bladder cancer versus transurethral electroresec-tion: single-center experience. Urology 2008; 72:608-612.
21. Ray ER, O'Brien TS. Should urologists be spending more time on the golf course? BJU Int 2007; 100:728-729.
22. Wilby D,Thomas K, Ray E, etal. Bladder cancer: new TUR techniques. World J Urol 2009; 27:309-312.
23. Jocham D, Stepp H, Waidelich R. Photodynamic diagnosis in urology: state-of-the-art. Eur Urol 2008; 53:1138-1150.
24. Hungerhuber E, Stepp H, Kriegmair M, et al. Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder. Urology 2007; 69:260-264.
25. Grossman HB, Gomella L, Fradet Y, et al. A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer. J Urol 2007; 178:62-67. (Pubitemid 46908731)
26. Fradet Y, Grossman HB, Gomella L, et al. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study. J Urol 2007; 178:68-73. (Pubitemid 46908730)
27. Schmidbauer J, Witjes F, Schmeller N, etal. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy. J Urol 2004; 171:135-138.
28. Daniltchenko DI, Riedl CR, Sachs MD, et al. Long-term benefit of 5-amino-levulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study. J Urol 2005; 174:2129-2133.
29. Denzinger S, Burger M, Walter B, et al. Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study. Urology 2007; 69:675-679.
30. Kriegmair M, Zaak D, Rothenberger KH, et al. Transurethral resection for bladder cancer using 5-aminolevulinic acid induced fluorescence endoscopy versus white light endoscopy. J Urol 2002; 168:475-478.
31. Stenzl AS, Roessler WR, Fradet YF, et al. Hexvix fluorescence cystoscopy improves detection and resection of papillary bladder cancer and reduces early recurrence: a multicentre, prospective, randomized study. Eur Urol Suppl 2009; 8:373-1373.
32. Burger M, Zaak D,StiefCG, etal. Photodynamic diagnostics and noninvasive bladder cancer: is it cost-effective in long-term application? A Germany-based cost analysis. Eur Urol 2007; 52:142-147.
33. Cauberg EC, de Bruin DM, Faber DJ et al. A new generation of optical diagnostics for bladder cancer: technology, diagnostic accuracy, and future applications. Eur Urol 2009. PMID: 19285787. [Epub ahead of print]
34. Bryan RT, Billingham LJ, Wallace DM. Narrow-band imaging flexible cysto-scopy in the detection of recurrent urothelial cancer of the bladder. BJU Int 2008; 101:702-705.
35. Herr HW, Donat SM. A comparison of white-light cystoscopy and narrow-band imaging cystoscopy to detect bladder tumour recurrences. BJU Int 2008; 102:1111-1114.
36. Hermes B, Spoler F, Naami A, et al. Visualization of the basement membrane zone of the bladder by optical coherence tomography: feasibility of noninvasive evaluation of tumor invasion. Urology 2008; 72:677-681.
37. Lerner SP, Goh AC, Tresser NJ, et al. Optical coherence tomography as an adjunct to white light cystoscopy for intravesical real-time imaging and staging of bladder cancer. Urology 2008; 72:133-137.